J3260 Injection, tobramycin sulfate, up to 80 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Tobramycin sulfate injection
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, tobramycin sulfate, up to 80 mg | yes |
Related codes in J32
- J3230 Injection, chlorpromazine hcl, up to 50 mg
- J3240 Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241 Injection, teprotumumab-trbw, 10 mg
- J3243 Injection, tigecycline, 1 mg
- J3244 Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 Injection, tildrakizumab, 1 mg
- J3246 Injection, tirofiban hcl, 0.25 mg
- J3247 Injection, secukinumab, intravenous, 1 mg
- J3250 Injection, trimethobenzamide hcl, up to 200 mg
- J3262 Injection, tocilizumab, 1 mg
- J3263 Injection, toripalimab-tpzi, 1 mg
- J3265 Injection, torsemide, 10 mg/ml
- J3285 Injection, treprostinil, 1 mg
- J3290 Injection, tranexamic acid, 5 mg
- J3291 Injection, tranexamic acid in sodium chloride, 5 mg
- J3299 Injection, triamcinolone acetonide (xipere), 1 mg